<DOC>
	<DOCNO>NCT01216150</DOCNO>
	<brief_summary>Aims Aspirin combine clopidogrel treatment choice acute coronary syndrome . Although maintenance aspirin surgery affect postoperative bleeding coronary artery bypass graft ( CABG ) surgery , latter may dramatically increase clopidogrel continued period 5 day preoperatively . Methods result : This prospective observational study include 136 consecutive patient schedule first-time CABG . Postoperative bleed blood transfusion requirement compare ( non inferiority ) patient pretreated period 5 day prior surgery either aspirin alone combine clopidogrel . Tranexamic acid systematically use patient consider high risk bleeding . In concusion , study test hypothesis tranexamic acid also , bleed aspirin + clopidogrel group 25 % important aspirin alone group CABG surgery , accord previous study use aprotinin .</brief_summary>
	<brief_title>Impact Combination Clopidogrel With Aspirin Postoperative Bleeding Coronary Surgical Patients</brief_title>
	<detailed_description>Impact combination clopidogrel aspirin postoperative bleed platelet function coronary surgical patient treat prophylactically tranexamic acid . Introduction Major cardiac event know reduced patient acute coronary syndrome association aspirin clopidogrel ( 1 ) ( 2 ) . In cardiac surgery well , aspirin treatment show reduce major cardio-vascular event mortality postoperative period coronary artery bypass grafting ( CABG ) without increase postoperative bleeding ( 3 ) ( 4 ) . In recent study perform department , Ouattara al . show cardiac surgery combination aspirin clopidogrel increase postoperative bleeding , transfusion surgical reexploration CABG aprotinin use surgery , comparison aspirin alone ( 5 ) . In conclusion , author suggest disruption aspirin clopidogrel patient treat association surgery . Unfortunately , since trial Mangano al . ( 6 ) BART investigator ( 7 ) , aprotinin , plasmin inhibitor derive bovine lung tissue , withdrawn safety reason . Therefore , physician restrain use instead tranexamic acid , synthetic molecule inhibits conversion inactive plasminogen plasmin , minimize bleed reduce exposure blood product . The aim study test hypothesis tranexamic acid also , bleed aspirin + clopidogrel group 25 % important aspirin alone group CABG surgery , accord previous study use aprotinin . In present study , functionality platelet test surgical procedure compare level first 24 hour bleed . Methods Selection patient This prospective observational study conduct Institute Cardiology Pitié-Salpêtrière Hospital , Paris , France . It plan start december 2009 november 2010 . Care patient conform standard procedure currently use institute , modify study . Platelet function measure residual blood sample , ethical committee approval ( Comité de Protection de Personnes VI - Ile de France ) . A write informed consent resquested patient . Nevertheless , write information deliver . During planned 11 month investigation , patient undergo isolated first-time coronary artery by-pass grafting enrol . Patients admit emergency procedure , follow fail percutaneous transluminal coronary angioplasty off-pump coronary surgery , exclude . Because antithrombotic therapy management may differ postoperative period , exclude patient mechanical support intra-aortic balloon pump require difficult wean cardiopulmonary bypass . Finally , exclude patient receive oral antiplatelet agent within 5 day prior surgery , preoperatively exposed platelet glycoprotein IIb/IIIa inhibitor , history haematological disease . Patients treat aspirin clopidogrel clopidogrel stop 5 day surgery also exclude . Intraoperative management Patients monitor arterial central venous catheterization . All patient consider high risk postoperative bleed receive least one antiplatelet agent therefore administer tranexamic acid ( Exacyl® , Sanofi-Aventis , Paris , France ) accord follow standardized protocol : infusion 10 mg/kg 20 minute anaesthesia induction , follow continuous infusion end surgery , accord renal function patient describe Nuttall et al . ( 8 ) ( See table ) . The rest intraoperative management previously describe Ouattara al . ( 5 ) . Briefly , aortic cannulation , initial load dose heparin directly administer surgeon right atrium anticoagulation maintain additional bolus extracorporeal circulation . Non-pulsatile cardiopulmonary bypass ensure flow 2.4 L/min/m2 . The temperature systemic perfusion cardiopulmonary bypass ( hypothermia &lt; 32°C , mild hypothermia 32-36°C , normothermia &gt; 36°C ) leave discretion attend surgeon . After discontinuation cardiopulmonary bypass , heparin neutralized protamin sulfate ( 0.008-0.01 mg/IU total heparin dose intraoperatively use ) . Intraoperative cell salvage systematically use ( Electa , Dideco , Mirandola , Italy ) . The use inotropes difficult wean cardiopulmonary bypass leave discretion attend anaesthesiologist . Discontinuation cardiopulmonary bypass do central body temperature ( estimate vesical temperature ) 35°C . Creatinine Tranexamic acid dose &lt; 140 µmol/L 2 mg/kg/h 140 - 290 µmol/L 1,5 mg/kg/h 291 - 580 µmol/L 1 mg/kg/h &gt; 580 µmol/L 0,5 mg/kg/h Table : dosing tranexamic acid accord renal function , Nuttall al . ( 8 ) Postoperative antithrombotic therapy The early postoperative antithrombotic therapy base intravenous bolus 100 mg aspirin give 6 h arrival intensive care unit , previously describe . The day surgery , enoxaparin 40 mg give daily subcutaneously . The perioperative blood transfusion do accord French National recommendation ( 9 ) . In patient preoperatively treat combined antiplatelet therapy , clopidogrel re-introduced day surgery . Antiplatelet therapy efficiency monitor Pre-operative platelet function include : 1 . Platelet aggregation test Aggregation study perform within 3 hour blood collection Pascale Gaussem ( INSERM U765 , HEGP ) , publish elsewhere ( 10 ) . Aggregation test perform platelet-rich plasma adjust 250x109/L platelet use follow agonist : arachidonic acid 1.5 2 mmol/l ( Helena biosciences Europe ) explore aspirin effect , Horm collagen 1 µg/ml explore global platelet function ( Nycomed Pharma ) ADP 10 20 µmol/l ( Biopool ) explore clopidogrel effect . A whole blood platelet impedance aggregation test perform use Multiplate® ( IL ) device various agonist . 2 . Flow cytometry assay VASP phosphorylation : clopidogrel effect VASP ( vasodilator-stimulated phosphoprotein ) measure whole blood commercial kit ( Platelet VASP ; Diagnostica Stago , Biocytex ) FACScan flow cytometer ( Becton Dickinson ) . The result express platelet reactivity index ( PRI , % ) . Secretory capacity platelet Platelet secretion test capacity expose surface P-selectin ( CD62P ) activation thrombin receptor peptide agonist ( TRAP ) publish elsewhere . Circulating platelet-leukocyte complex Circulating activated platelet form complexes leukocyte via CD62P-PSGL interaction . These complex quantify population 5000 leukocytes . Complexes identify flow cytometry cell population stain anti-CD41-PE ( platelet marker ) anti-CD45-FITC ( leukocyte marker ) express percentage total leukocyte . Endpoints The primary outcome chest blood output first 24 hour . Size sample calculation : bleeding aspirin alone estimate around 400±200 mL CABG ( 5 ) . Excessive bleeding define increment least 25 % basal value collect chest tube first 24 postoperative hour . Secondary outcome rate re-exploration excessive bleeding , transfusion requirement , prolong mechanical ventilation ( &gt; 10 h ) , intensive care unit length stay ( &gt; 72 h ) . Statistical analysis With estimate distribution 60 % / 40 % aspirin alone aspirin + clopidogrel group assume alpha risk 0.05 beta risk 0.20 mean amount postoperative bleeding CABG aspirin-alone group 400 +/- 200 mL , calculate least 136 patient ( 85 aspirin alone 51 aspirin + clopidogrel ) require demonstrate amount bleed aspirin+clopidogrel 25 % increase compare bleed aspirin alone group ( non inferiority study ) . Lastly , suppose patient lose follow several technical problem sample collection platelet function analysis , final number patient include estimate 150 thus predict duration inclusion 44 week . Categorical variable compare use Fisher 's exact test continuous variable use Mann-Witney U test . The postoperative hemoglobin level platelet count compare use analysis variance repeat measurement complete use Newman-Keuls test post-test analysis . Since study randomize , patient receive clopidogrel preoperatively may peri-operative risk excessive bleeding . Therefore , perform separate multivariable risk adjustment analyze perioperative risk associate clopidogrel treatment . For patient , propensity score , indicate likelihood clopidogrel , calculate . The propensity score-matched analysis allow u determine whether preoperative clopidogrel therapy independently associate increase risk excessive postoperative bleeding . All preoperative variable well second-order interaction term enter model . Calibration discrimination final logistic model assess use Hosmer-Lemeshow statistic receiver operate characteristic curve , respectively . Comparison mean bleed several group ( accord propensity score quintiles ) perform use analysis variance . Data express mean+SD , median , 5th-95th percentile percentage patient specify . All P-values two tail value le 0.05 required reject null hypothesis . References 1 . Fox KAA , Mehta SR , Peters R , Zhao F , Lakkis N , Gersh BJ , Yusuf S. Benefits risk combination clopidogrel aspirin patient undergoing surgical revascularization non-ST-elevation acute oronary syndrome . The clopidogrel unstable angina prevent recurrent ischaemic event ( CURE ) trial . Circulation . 2004 , Vol . 110 , pp . 1202-1208 . 2 . The clopidogrel unstable angina prevent recurrent ischaemic event trial investigator . Effects clopidogrel addition aspirin patient acute coronary syndrome without ST-segment elevation . N Engl J Med . 2001 , 345 , pp . 494-502 . 3 . Tuman KJ , McCarthy RJ , O'Connor CJ , McCarthy WE , Ivankovich AD . Aspirin increase allogenic blood transfusion reoperative coronary artery surgery . Anesth Analg . 1996 , Vol . 83 , pp . 1178-1184 . 4 . Dacey LJ , Munoz JJ , Johnson ER , Leavitt BJ , Maloney CT , Morton JR , Olmstead EM , Birkmeyer JD , O'Connor GT Northern New England Cardiovascular . Effect preoperative aspirin use mortality coronary artery bypass graft patient . Ann Thorac Surg . 2000 , Vol . 70 , pp . 1986-1990 . 5 . Ouattara A , Bouzguenda H , Le Manach Y , Léger Ph , Mercadier A , Leprince P , Bonnet N , Montalescot G , Riou B , Coriat P. Impact aspirin without clopidogrel postoperative bleeding blood transfusion coronary surgical patient treat prophylactically low-dose aprotinin . Eur Heart J . 2007 , Vol . 28 , pp . 1025-1032 . 6 . Mangano DT , Tudor IC , Dietzel C , Group , Multicenter Study Preoperative Ischemia Research et Fondation , Ischemia Research Education . The risk associate aprotinin cardiac surgery . N Engl J Med . 2006 , Vol . 354 ( 4 ) , pp . 353-65 . 7 . Fergusson DA , Hébert PC , Mazer CD , Fremes S , MacAdams C , Murkin JM , Teoh K , Duke PC , Arellano R , Blajchman MA , Bussières JS , Côté D , Karski J , Martineau R , Robblee JA , Rodger M , Welles G , Clinch J , Pretorius R , BART investigator . A comparison aprotinin lysine analogue high risk cardiac surgery . N Engl J Med . 2008 , Vol . 358 , 22 , pp . 2319-2331 . 8 . Nuttal GAl , Gutierrez MC , Dewey JD . A Preliminary Study New Tranexamic Acid Dosing Schedule Cardiac Surgery . Journal Cardiothoracic Vascular Anesthesia . 2008 , Vol . 22 , 2 , pp . 230-235 . 9 . Agence Française de Sécuité Sanitaire des Produits de Santé ( AFSSAPS ) . Transfusion erythrocytes substitute : product , indication , alternative . General method recommendation . Transfus Clin Biol . 2002 , Vol . 9 , pp . 333-356 . 10 . Dupont A , Fontana P , Bachelot-Loza C , Reny JL , Bieche I , Desvard F , et al . An intronic polymorphism PAR-1 gene associate platelet receptor density response SFLLRN . Blood 2003 ; 101:1833-40 .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>patient undergo isolated firsttime coronary artery bypass graft enrol . patient want include pregnant patient &lt; 18 yr old emergency procedure fail percutaneous transluminal coronary angioplasty offpump coronary surgery patient mechanical support ( ECMO ) intraaortic balloon pump require difficult wean cardiopulmonary bypass patient receive oral antiplatelet agent within 5 day prior surgery patient preoperatively exposed platelet glycoprotein IIb/IIIa inhibitor Patients treat aspirin clopidogrel clopidogrel stop 5 day surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>antifibrinolytic drug</keyword>
	<keyword>coronary surgery</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
</DOC>